Thompson CB - Search Results

1

The Emerging Hallmarks of Cancer Metabolism.

Pavlova NN, Thompson CB. Pavlova NN, et al. Among authors: thompson cb. Cell Metab. 2016 Jan 12;23(1):27-47. doi: 10.1016/j.cmet.2015.12.006. Cell Metab. 2016. PMID: 26771115 Free PMC article. Review.

2

PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis.

Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A, Miura J, Wiener HH, Wright L, Saba SG, Yim D, Fein A, Pérez de Castro I, Li C, Thompson CB, Cox AD, Philips MR. Bivona TG, et al. Among authors: thompson cb. Mol Cell. 2006 Feb 17;21(4):481-93. doi: 10.1016/j.molcel.2006.01.012. Mol Cell. 2006. PMID: 16483930

3

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. DeBerardinis RJ, et al. Among authors: thompson cb. Cell Metab. 2008 Jan;7(1):11-20. doi: 10.1016/j.cmet.2007.10.002. Cell Metab. 2008. PMID: 18177721 Review.

4

Tumor suppressors and cell metabolism: a recipe for cancer growth.

Jones RG, Thompson CB. Jones RG, et al. Among authors: thompson cb. Genes Dev. 2009 Mar 1;23(5):537-48. doi: 10.1101/gad.1756509. Genes Dev. 2009. PMID: 19270154 Free PMC article. Review.

5

Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation.

Gruber JJ, Zatechka DS, Sabin LR, Yong J, Lum JJ, Kong M, Zong WX, Zhang Z, Lau CK, Rawlings J, Cherry S, Ihle JN, Dreyfuss G, Thompson CB. Gruber JJ, et al. Among authors: thompson cb. Cell. 2009 Jul 23;138(2):328-39. doi: 10.1016/j.cell.2009.04.046. Cell. 2009. PMID: 19632182 Free PMC article.

6

Q&A: Cancer: clues from cell metabolism.

Kaelin WG Jr, Thompson CB. Kaelin WG Jr, et al. Among authors: thompson cb. Nature. 2010 Jun 3;465(7298):562-4. doi: 10.1038/465562a. Nature. 2010. PMID: 20520704 No abstract available.

7

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, Tallman MS, Sun Z, Wolniak K, Peeters JK, Liu W, Choe SE, Fantin VR, Paietta E, Löwenberg B, Licht JD, Godley LA, Delwel R, Valk PJ, Thompson CB, Levine RL, Melnick A. Figueroa ME, et al. Among authors: thompson cb. Cancer Cell. 2010 Dec 14;18(6):553-67. doi: 10.1016/j.ccr.2010.11.015. Epub 2010 Dec 9. Cancer Cell. 2010. PMID: 21130701 Free PMC article.

8

Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production.

Ward PS, Cross JR, Lu C, Weigert O, Abel-Wahab O, Levine RL, Weinstock DM, Sharp KA, Thompson CB. Ward PS, et al. Among authors: thompson cb. Oncogene. 2012 May 10;31(19):2491-8. doi: 10.1038/onc.2011.416. Epub 2011 Sep 26. Oncogene. 2012. PMID: 21996744 Free PMC article.

9

Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability.

Wise DR, Ward PS, Shay JE, Cross JR, Gruber JJ, Sachdeva UM, Platt JM, DeMatteo RG, Simon MC, Thompson CB. Wise DR, et al. Among authors: thompson cb. Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19611-6. doi: 10.1073/pnas.1117773108. Epub 2011 Nov 21. Proc Natl Acad Sci U S A. 2011. PMID: 22106302 Free PMC article.

10

IDH mutation impairs histone demethylation and results in a block to cell differentiation.

Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, Wellen KE, O'Rourke DM, Berger SL, Chan TA, Levine RL, Mellinghoff IK, Thompson CB. Lu C, et al. Among authors: thompson cb. Nature. 2012 Feb 15;483(7390):474-8. doi: 10.1038/nature10860. Nature. 2012. PMID: 22343901 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results